| Literature DB >> 16263588 |
Matthew T Bennett1, Sandra Sirrs, Janice K Yeung, Clayton A Smith.
Abstract
All-trans-retinoic acid (ATRA) is a new and effective treatment of acute promyelocytic leukemia. It has many side-effects, including the retinoic acid syndrome and Sweet's syndrome. There have been only nine cases of hypercalcemia associated with ATRA described in the literature. We discuss a case of hypercalcemia, which we believe was due to inhibition of cytochrome P450 function by voriconizole when used concomitantly with ATRA.Entities:
Mesh：
Substances：
Year: 2005 PMID： 16263588 DOI： 10.1080/10428190500235298
Source DB: PubMed Journal: Leuk Lymphoma ISSN： 1026-8022